Cite
Seki JT, Sakurai N, Moldenhauer S, et al. Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. Curr Oncol. 2015;22(5):e357-63doi: 10.3747/co.22.2620.
Seki, J. T., Sakurai, N., Moldenhauer, S., Dam, J., Atenafu, E. G., Yip, P. M., Mazzulli, T., Henderson, T., Pendergrast, J., Cserti, C., Velazquez, J. P., Simpson, R., Felluga, G., Messner, H. A., & Lipton, J. H. (2015). Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. Current oncology (Toronto, Ont.), 22(5), e357-63. https://doi.org/10.3747/co.22.2620
Seki, J T, et al. "Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting." Current oncology (Toronto, Ont.) vol. 22,5 (2015): e357-63. doi: https://doi.org/10.3747/co.22.2620
Seki JT, Sakurai N, Moldenhauer S, Dam J, Atenafu EG, Yip PM, Mazzulli T, Henderson T, Pendergrast J, Cserti C, Velazquez JP, Simpson R, Felluga G, Messner HA, Lipton JH. Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. Curr Oncol. 2015 Oct;22(5):e357-63. doi: 10.3747/co.22.2620. PMID: 26628876; PMCID: PMC4608409.
Copy
Download .nbib